Home / Specialties... / Doctors
Xiaolong Liao/Associate chief physician

Specialties:Critical Care Medicine


Clinical Interests: myocardial ischemic injury, maintenance of a stable internal environment, assessment of diaphragm’s funciton, airway management


Bio

(1) 2021-present, Department of Critical Care Medicine, Guangdong Provincial People's Hospital,Associate chief physician

(2)2012.7-2020.12, Department of Critical Care Medicine, Guangdong Provincial People's Hospital, Attending Physician

(3) Actively participate in the treatment of the new crown pneumonia epidemic in 2020


Education

Ph.D. Cardiac Surgery, Sun Yat-sen University, Guangzhou, China, 2009-2012

M.D. Urology surgery, Harbin Medical University, Harbin, China, 2004-2007.

B.S. Clinic Medicine, Shantou University, Shantou, China, 1993-1998.


RESEARCH EXPERIENCE:

1. Development of mouse models of myocardial ischemic preconditioning(IPC) and ischemic post-conditioning (IPD) by a modified method. The method included lung recruitment and short-term ventilation. The method significantly increased the survival of mice with IPC or IPD, and other myocardial ischemia.

2.The research involves the study of myocardial ischemic injury in aging, which has been approved “lost cardioprotection” in other studies. The research is about inflammatory responses to cardiac ischemia in aging and how to improve carioprotection by conditioning, such as preconditioning, postconditioning, and remote conditiong.


Publications:

1.Liao XL, XiaoXia Hu, FengJun Chang, HaiYun Yuan, HongBo Ci, JiaYun Wu, Zhengyuan XIA, Zhi-Ping Wang, Xi Zhan, JingSong Ou* A simple modification results in greater success in the models of coronary artery ligation and myocardial ischemia in mice. J Cardiovasc Pharmacol. 2013 May;61(5):430-6. IF=2.287

2.Xie JJ, Liao XL(co-author),Chen WG, Huang DD, Chang FJ, Chen W, Luo ZL, Wang ZP, Ou JS Remote ischemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: a randomized controlled trial. Heart. 2012;98:384-388.IF=4.706

3.Zhi-Jun Ou, Li Li, Liao XL, Yi-Ming Wang, Xiao-Xia Hu, Qing-Li Zhang, Zhi-Ping Wang, Huan Yu, Xi Zhang, Ping Hu, Ying-Qi Xu, Qiong-Lin Liang, Jing-song Ou, and Guoan Luo. Apolipoprotein A-I mimetic peptide inhibited atherosclerosis by altering plasma metabolites in hypercholesterolemia. American Journal of Physiology- Endocrinology and Metabolism. 2012, Apr 24. [Epub ahead of print]. IF=4.686